- metadata:
- source: https://ukfreedomproject.org/covid-19-vaccines-yellow-card-analysis/
---
# COVID-19 Vaccines Yellow Card Analysis – UK Freedom Project
> ## Excerpt
>
---
Data is a precious thing and will last longer than the systems themselves.
Our analysis of the Medical & Healthcare products Regulation Agency (MHRA) Yellow Card Scheme for COVID-19 vaccines uses the publicly available [weekly reports](https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting) that are released by the MHRA. Regrettably, the MHRA overwrites the report each week, so the only download available to the general public at any given time is the summary at that particular point. Without access to preceding reports, the snapshot their document provides allows for little analysis.
Fortunately, we have managed to obtain copies of every weekly report going back to the start of the COVID-19 vaccine rollout and have therefore been able to build a more detailed picture of how adverse reactions have developed over time.
The MHRA does a weekly “cut off” of data but then takes several days to make the summary report available on its [website](https://www.gov.uk/government/publications/coronavirus-covid-19-vaccine-adverse-reactions/coronavirus-vaccine-summary-of-yellow-card-reporting). So at times we can be looking at information that is two weeks out of date. Given that millions are receiving vaccines each week, we are concerned that this time lag introduces additional risk as well as restricting the ability of an individual to make a truly [informed decision](https://ukfreedomproject.org/consent-to-treatment/) about having the vaccine based on up to date risk information.
We are also hampered by incomplete data so have deliberately held back from drawing conclusions based on the data we have. Instead, we aim to provide insights into what we do know so that we, and you, can ask more meaningful questions of the MHRA, the government, vaccine manufacturers – and your own healthcare providers.
- How many 1st and 2nd doses of each vaccine brand have been administered
- How many adverse reactions have been reported
- How many deaths have been reported
- How each reaction & death has been classified in fine detail
- Whether a death or reaction reported was caused by the vaccine or a coincidence
- Whether a death or reaction report relates to a 1st or 2nd dose
- Time between dose and death or reaction
- Time between death or reaction & reporting
- Demographic information of patient (gender, age, health status)
- If a patient has had multiple reactions
- Patterns of combinations of reactions
- How many deaths & reactions haven't been reported
- Whether vaccine mixing has taken place
- If changes in storage guidance for vaccines have impacted reactions
- Whether patients reporting adverse reactions had previously had or tested positive for COVID-19
As we began our first look at the week by week data, it came to our attention that Dr Tess Lawrie (MBBCh, PhD), of the [Evidence-based Medicine Consultancy](https://www.e-bmc.co.uk/), was about to undertake a similar task. We therefore reached out and agreed that we would pool our technical skills and her medical expertise to better understand and analyse the data.
An important discovery was that similar conditions had been classified in many different ways. Dr Lawrie’s medical knowledge helped us to better group similar conditions together. Once we did that, it became clear that there were far higher incidences of some reactions than a cursory glance of the MHRA report would suggest.
Dr Lawrie was so concerned about what she saw that she immediately presented the findings in an open letter to Dr June Raine, Chief Executive of the MHRA. As well as presenting the findings, the letter also called for an immediate halt of the COVID-19 vaccine rollout until more detailed analysis of the Yellow Card data can be carried out.
With the rollout continuing, Dr Lawrie sent a follow up letter in September 2021 highlighting even more concerns, particularly that the suspected deaths per million doses was 28 times higher than for the flu vaccines.
## Yellow Card Summary to 20th October 2021
Pfizer/ BioNTech
AstraZeneca
Moderna
Unspecified
Totals
Rollout Start Date
08/12/20
04/01/21
07/04/21
n/a
n/a
First Doses Administered
23.2 million
24.9 million
1.5 million
n/a
49.6 million
Second Doses Administered
20.1 million
24.0 million
1.3 million
n/a
45.4 million
Adverse Reactions
350,870
835,090
54,555
3,483
1,243,998
Deaths
576
1,111
20
31
1,738
#### New reactions this week = 7,513
#### New deaths this week = 23
45.5%51.5%
Brand
Doses
Pfizer/BioNTech
43,300,000
AstraZeneca
49,000,000
Moderna
2,800,000
Unspecified
0
28.2%67.1%
Brand
Adverse Reactions
Pfizer/BioNTech
350,870
AstraZeneca
835,090
Moderna
54,555
Unspecified
3,483
33.1%63.9%
Brand
Deaths
Pfizer/BioNTech
576
AstraZeneca
1,111
Moderna
20
Unspecified
31
Condition
No of Reactions
No of Deaths
Headache
107,386
0
Fatigue
71,995
0
Pyrexia
70,565
1
Chills
52,614
0
Nausea
47,432
0
Myalgia
37,528
0
Pain in extremity
35,073
0
Dizziness
32,864
0
Arthralgia
31,597
0
Pain
26,173
0
Malaise
17,411
0
Rash
15,820
1
Vomiting
15,773
1
Lymphadenopathy
15,401
0
Pruritus
14,481
0
Diarrhoea
14,025
2
Paraesthesia
13,707
0
Influenza like illness
11,852
0
Dyspnoea
11,817
6
Hyperhidrosis
11,644
0
Condition
No of Deaths
Death (no further information available)
473
Pulmonary embolism
136
Myocardial infarction
87
Cardiac arrest
73
COVID-19
69
Sudden death
67
Cerebrovascular accident
61
Cerebral haemorrhage
55
Thrombosis
45
Pneumonia
43
Cerebral venous sinus thrombosis
26
COVID-19 pneumonia
23
Sepsis
20
Cardiac failure
20
Multiple organ dysfunction syndrome
17
Myocardial ischaemia
16
Haemorrhage intracranial
16
Acute myocardial infarction
14
Abortion spontaneous
14
Subarachnoid haemorrhage
13
## REACTIONS & DEATHS BY TYPE (SOC)
Type of Reaction (System of Care)
Reactions
Deaths
Blood disorders
20,587
16
Cardiac disorders
16,560
279
Congenital disorders
176
1
Ear disorders
15,438
1
Endocrine disorders
674
0
Eye disorders
20,665
0
Gastrointestinal disorders
116,467
31
General disorders
354,731
581
Hepatic disorders
661
10
Immune system disorders
5,175
7
Infections
28,056
196
Injuries
15,387
3
Investigations
16,054
4
Metabolic disorders
11,008
5
Muscle & tissue disorders
148,617
1
Neoplasms
731
15
Nervous system disorders
247,205
257
Pregnancy conditions
1,182
28
Psychiatric disorders
26,014
7
Renal & urinary disorders
3,722
12
Reproductive & breast disorders
45,074
1
Respiratory disorders
44,858
193
Skin disorders
83,590
3
Social circumstances
633
0
Surgical & medical procedures
1,268
1
Vascular disorders
19,465
86
Created with Highcharts 9.3.1Week Number (Week 1 = 24/01/21)Doses (millions)AstraZeneca 1st DoseAstraZeneca 2nd DosePfizer/BioNTech 1st DosePfizer/BioNTech 2nd DoseModerna 1st DoseModerna 2nd Dose123456789101112131415161718192021222324252627282930313233343536373839\-10123456
###### Weeks with negative doses are not our error but are where the totals contained in the MHRA reports are lower than the preceding week. We do not know if this is due to a clerical error in the preparation of the current weekly report, a correction of clerical errors made in previous reports or a correction due to errors in the past reporting of doses to the MHRA.
### Further analysis coming soon
#### In the meantime, if you'd like to find out more about COVID-19 vaccines, the Public Health England weekly surveillance reports may prove useful:
#### If you'd like to find out about adverse reactions recorded in other countries, here are some useful links: